tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
PremiumRatingsBuy Rating for Rapport Therapeutics, Inc. Driven by Promising Phase IIa Trial and RAP Technology Potential
9d ago
Premium
Ratings
Buy Rating for Rapport Therapeutics: RAP-219’s Promising Potential in Epilepsy Treatment
9d ago
Rapport Therapeutics initiated with a Buy at H.C. Wainwright
Premium
The Fly
Rapport Therapeutics initiated with a Buy at H.C. Wainwright
10d ago
Rapport Therapeutics management to meet with Citizens JMP
PremiumThe FlyRapport Therapeutics management to meet with Citizens JMP
2M ago
Premium
Company Announcements
Rapport Therapeutics Completes Enrollment for Phase 2a Trial
2M ago
Premium
Company Announcements
Rapport Therapeutics Reports Q1 2025 Financial Results
3M ago
PremiumRatingsBuy Rating for Rapport Therapeutics: Promising Precision Therapeutics for CNS Disorders
4M ago
Rapport Therapeutics initiated with an Outperform at Citizens JMP
Premium
The Fly
Rapport Therapeutics initiated with an Outperform at Citizens JMP
4M ago
Rapport Therapeutics to present data at 2025 AAN meeting
Premium
The Fly
Rapport Therapeutics to present data at 2025 AAN meeting
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100